Magali Bouvier‐Alias

3.5k total citations
49 papers, 1.6k citations indexed

About

Magali Bouvier‐Alias is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Magali Bouvier‐Alias has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 31 papers in Epidemiology and 18 papers in Infectious Diseases. Recurrent topics in Magali Bouvier‐Alias's work include Hepatitis C virus research (35 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (17 papers). Magali Bouvier‐Alias is often cited by papers focused on Hepatitis C virus research (35 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (17 papers). Magali Bouvier‐Alias collaborates with scholars based in France, United States and Germany. Magali Bouvier‐Alias's co-authors include Jean–Michel Pawlotsky, Stéphane Chevaliez, Christophe Hézode, Rozenn Brillet, Daniel Dhumeaux, Françoise Roudot‐Thoraval, Jocelyne Rémiré, Françoise Darthuy, Ariane Mallat and Alexandre Soulier and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Magali Bouvier‐Alias

46 papers receiving 1.5k citations

Peers

Magali Bouvier‐Alias

HEPAT

EPIDE

VIROL

RHEUM

Y. Benhamou France

Janusz Cianciara Poland

Anne Mette Hoegh Denmark

B Myrvang Norway

Florian van Bömmel Germany

Mei-Hsiu Ling United States

Jiaji Jiang China

Fiorella Balli Italy

V. Carreño Spain

Sukanya Raghuraman India

Y. Benhamou France

Magali Bouvier‐Alias

1.2k ×1.0

HEPAT

1.3k ×1.0

EPIDE

337 ×0.9

72 ×0.6

VIROL

48 ×0.5

RHEUM

Citations per year, relative to Magali Bouvier‐Alias Magali Bouvier‐Alias (= 1×) peers Y. Benhamou

Countries citing papers authored by Magali Bouvier‐Alias

Since Specialization

Citations

This map shows the geographic impact of Magali Bouvier‐Alias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Bouvier‐Alias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Bouvier‐Alias more than expected).

Fields of papers citing papers by Magali Bouvier‐Alias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Bouvier‐Alias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Bouvier‐Alias. The network helps show where Magali Bouvier‐Alias may publish in the future.

Co-authorship network of co-authors of Magali Bouvier‐Alias

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Bouvier‐Alias. A scholar is included among the top collaborators of Magali Bouvier‐Alias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Bouvier‐Alias. Magali Bouvier‐Alias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wirden, Marc, Marie‐Laure Chaix, Stéphanie Marque‐Juillet, et al.. (2025). Benefits of HIV‐1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co‐evolution of recent circulating recombinant forms 94 and 132. Journal of the International AIDS Society. 28(2). e26416–e26416. 1 indexed citations

Zafilaza, Karen, Vincent Foulongne, Maud Salmona, et al.. (2024). Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study. Viruses. 16(10). 1542–1542.

Fourati, Slim, Alexandre Soulier, Anne Le Bouter, et al.. (2021). Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use. Journal of Clinical Virology. 146. 105048–105048. 7 indexed citations

Thibault, Vincent, Gisèle Lagathu, Gilles Duverlie, et al.. (2019). Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study. Epidemiology and Infection. 147. e234–e234. 3 indexed citations

Rodriguez, Christophe, Alexandre Soulier, Vanessa Démontant, et al.. (2018). A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination. Scientific Reports. 8(1). 4180–4180. 17 indexed citations

Oliveira, Fabienne De, Pierre Cappy, Alice Moisan, et al.. (2018). Detection of numerous HIV-1/MO recombinants in France. AIDS. 32(10). 1289–1299. 5 indexed citations

Dufeu‐Duchesne, Tania, Vincent Leroy, Magali Bouvier‐Alias, et al.. (2016). Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion. PLoS ONE. 11(6). e0158297–e0158297. 19 indexed citations

Belle, Arthur, Emmanuel Gizard, Guillaume Conroy, et al.. (2016). 25‐OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV‐infected patients. United European Gastroenterology Journal. 5(1). 69–75. 10 indexed citations

Seignères, B., Valérie Barlet, Magali Bouvier‐Alias, et al.. (2016). Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS® system. Journal of Clinical Virology. 78. 20–26. 6 indexed citations

10.

Chevaliez, Stéphane, Alexandre Soulier, Lila Poiteau, Magali Bouvier‐Alias, & Jean–Michel Pawlotsky. (2014). Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C. Journal of Clinical Virology. 61(1). 145–148. 52 indexed citations

11.

Dominguez, Stéphanie, Jade Ghosn, Giovanna Melica, et al.. (2012). Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV. Journal of Antimicrobial Chemotherapy. 67(6). 1449–1452. 9 indexed citations

12.

Hézode, Christophe, Laurent Castéra, Françoise Roudot‐Thoraval, et al.. (2011). Liver stiffness diminishes with antiviral response in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 34(6). 656–663. 102 indexed citations

13.

Chevaliez, Stéphane, Christophe Hézode, Alexandre Soulier, et al.. (2011). High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). Gastroenterology. 141(1). 119–127. 23 indexed citations

14.

Melica, Giovanna, Ana Canestri, Gilles Peytavin, et al.. (2010). Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms. AIDS. 24(13). 2130–2133. 22 indexed citations

15.

Chevaliez, Stéphane, Magali Bouvier‐Alias, Rozenn Brillet, & Jean–Michel Pawlotsky. (2009). Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice. PLoS ONE. 4(12). e8209–e8209. 95 indexed citations

16.

Hézode, Christophe, Isabelle Rosa, Laurent Castéra, et al.. (2007). [597] EVOLUTION OF LIVER STIFFNESS MEASUREMENT DURING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 46. S226–S226. 1 indexed citations

17.

Hézode, Christophe, Élie Serge Zafrani, Françoise Roudot‐Thoraval, et al.. (2007). Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C. Gastroenterology. 134(2). 432–439. 138 indexed citations

18.

Hézode, Christophe, Stéphane Chevaliez, Magali Bouvier‐Alias, et al.. (2007). Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg daily. Journal of Hepatology. 46(5). 791–796. 26 indexed citations

19.

Bronowicki, Jean–Pierre, Denis Ouzan, Tarik Asselah, et al.. (2006). Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin. Gastroenterology. 131(4). 1040–1048. 148 indexed citations

20.

Bouvier‐Alias, Magali, Keyur Patel, Harel Dahari, et al.. (2002). Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology. 36(1). 211–218. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact